by In2Pharma | Dec 12, 2018 | News
EU Versions 11 & 12 of the Q&A on Safety features for medicinal products for human use have been published in October and November of 2018. Following these updates, multiple questions have been revised (1.20; 1.23; 2.21; 7.15; 8.4; 8.7) and some new questions...
by In2Pharma | Feb 12, 2018 | News
FAMHP It is not allowed for Wholesaler’s Distribution Authorization (WDA) holders to purchase medicines from companies based outside the European Economic Area (EEA) if these medicines were manufactured within the EEA and released by the qualified person of the...
by In2Pharma | Feb 12, 2018 | News
FAMHP The guidelines on labeling of medicines have been adapted. With these adaptations, the guidelines are more in line with the European and other national and international guidelines. Main changes are: Information in braille: the strength and/or pharmaceutical...
